Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 7, 2011, Pages 1492-1501

  Guittet, Lydia ^a   Guillaume, Elodie ^a   Levillain, Romuald ^b   Beley, Philippe ^b   Tichet, Jean ^b   Lantieri, Olivier ^b   Launoy, Guy ^a  

^a UNIVERSITÉ DE CAEN   (France)

^b IRSA Institut Inter Régional Pour la Santé   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ADULT; ARTICLE; CANCER SCREENING; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FECES ANALYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; NORMAL HUMAN; OCCULT BLOOD TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY;

COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; HUMANS; IMMUNOHISTOCHEMISTRY; MASS SCREENING; OCCULT BLOOD; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING;

EID: 79960105485     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-0594     Document Type: Article

References (18)

1. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103:1541-9. (Pubitemid 351813919)
2. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, et al. Comparison of guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 2007;56:210-4.
3. Van Rossum LG, Van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90. (Pubitemid 351899018)
4. Hol L, Wilschut JA, van Ballegooijen M, van Vuuren AJ, van der Valk H, Reijerink JC, et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. Br J Cancer 2009;100:1103-10.
5. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 2007;146:244-55. (Pubitemid 351650610)
6. Grazzini G, Visioli CB, Zorzi M, Ciatto S, Banovich F, Bonanomi AG, et al. Immunochemical faecal occult blood test: number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? Br J Cancer 2009;100:259-65.
7. Guittet L, Bouvier V, Mariotte N, Vallee JP, Levillain R, Tichet J, et al. Performances of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples. Int J Cancer 2009;125:1127-33.
8. van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, Jansen JB, et al. Cutoff value determines the performance of a semiquantitative immunochemical faecal occult blood test in a colorectal cancer screening programme. Br J Cancer 2009;101:1274-81.
9. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. preventive services task force recommendation statement. Ann Int Med 2008;149:627-37.
10. Lieberman DA. Clinical practice. Screening for colorectal cancer. N Engl J Med 2009;361:1179-87.
11. van Rossum LG, van Rijn AF, van Oijen MG, Fockens P, Laheij RJ, Verbeek AL, et al. False negative fecal occult blood tests due to delayed sample return in colorectal cancer screening. Int J Cancer 2009;125:746-50.
12. Grazzini G, Ventura L, Zappa M, Ciatto S, Confortini M, Rapi S, et al. Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from Florence district. Gut 2010;59:1511-5.
13. Australian Government, Department of Health and Aging. National bowel cancer screening program: screening retest fact sheet. [accessed 2010 Sept 13]. Available from: www.cancerscreening.gov.au/internet/screening/publishing.nsf/ content/bw-retest
14. Rozen P, Waked A, Vilkin A, Levi Z, Niv Y. Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood. Med Sci Monit 2006;12:MT27-32.
15. Ciatto S, Martinelli F, Castiglione G, Mantellini P, Rubeca T, Grazzini G, et al. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the florence screening programme. Br J Cancer 2007;96:218-21 (Pubitemid 46160624)
16. NHS Evaluation report. Immunochemical faecal occult blood tests; 2009 Nov. Report No.: CEP09042.
17. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8. (Pubitemid 41096630)
18. Guittet L, Bouvier V, Mariotte N, Vallee JP, Levillain R, Tichet J, et al. Comparison of a guaiac and an immunochemical fecal occult blood test for the detection of colonic lesions according to lesion type and location. Br J Cancer 2009;100:1230-5.